Patents by Inventor Kwang-ho Cheong

Kwang-ho Cheong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-C-MET ANTIBODY AND USES THEREOF
    Publication number: 20210269533
    Abstract: An anti-c-Met antibody or antibody fragment and pharmaceutical composition comprising same, as well as a method for preventing and treating cancer by administering the antibody to a subject are provided.
    Type: Application
    Filed: March 5, 2021
    Publication date: September 2, 2021
    Inventors: Seung Hyun LEE, Geun Woong KIM, Kyung Ah KIM, Hye Won PARK, Ho Yeong SONG, Young Mi OH, Saet Byoul LEE, Ji Min LEE, Kwang Ho CHEONG, Yun Ju JEONG, Mi Young CHO, Jae Hyun CHOI, Yun Jeong SONG, Yoon Aa CHOI
  • Bispecific anti-Cmet/anti-Her2 antibodies
    Patent number: 10143749
    Abstract: There are provided an anti-c-Met/anti-Her2 bispecific antibody, and a method for preventing and/or treating cancer using the same.
    Type: Grant
    Filed: March 28, 2014
    Date of Patent: December 4, 2018
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Mi Young Cho, Powei Lin, Seung Hyun Lee, Kwang Ho Cheong, Young Jun Koh, Christina Yi, Jae Woong Hwang
  • Anti-cMet/anti-EGFR/anti-HER3 multispecific antibodies and use thereof
    Patent number: 10000569
    Abstract: An anti-EGFR/anti-HER3 antibody or antigen binding fragment thereof, and a method of preventing and/or treating a cancer using the same.
    Type: Grant
    Filed: April 22, 2015
    Date of Patent: June 19, 2018
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Kwang Ho Cheong, Jae Woong Hwang, Seung Hyun Lee, Powei Lin, Mi Young Cho
  • Anti-HER2 antibody and anti-c-Met/anti-HER2 bispecific antibodies comprising the same
    Patent number: 9975960
    Abstract: An anti-HER2 antibody, an anti-c-Met/anti-HER2 bispecific antibody including the same, method for preparing same, and a method of preventing and/or treating a cancer using the same are provided.
    Type: Grant
    Filed: May 11, 2015
    Date of Patent: May 22, 2018
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Mi Young Cho, Powei Lin, Kwang Ho Cheong, Jae Woong Hwang, Geun Woong Kim, Han Na Choi
  • Anti-EGFR antibody and anti-c-Met/anti-EGFR bispecific antibodies comprising the same
    Patent number: 9902776
    Abstract: An anti-EGFR scFV fragment, an anti-c-Met/anti-EGFR bispecific antibody including the same, and a method of preventing and/or treating a cancer using the same are provided.
    Type: Grant
    Filed: July 29, 2014
    Date of Patent: February 27, 2018
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Mi Young Cho, Seung Hyun Lee, Kwang Ho Cheong, Young Jun Koh, Jung Wook Lee, Powei Lin, Jae Woong Hwang
  • Combination therapy using bispecific anti-c-Met/anti-EGFR antibody and c-Src inhibitor
    Patent number: 9730926
    Abstract: Pharmaceutical composition including a bispecific anti-c-Met/anti-EGFR antibody and a c-Src inhibitor and a method of preventing and/or treating cancer including co-administering a bispecific anti-c-Met/anti-EGFR antibody and a c-Src inhibitor to a subject in need thereof.
    Type: Grant
    Filed: January 20, 2015
    Date of Patent: August 15, 2017
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Powei Lin, Kwang Ho Cheong, Young Jun Koh, Jae-woong Hwang, Seung Hyun Lee, Jung Wook Lee
  • Method of combination therapy using an anti-C-Met antibody
    Patent number: 9717715
    Abstract: A method for prevention or treatment of a cancer, comprising co-administering (a) an anti-c-Met antibody or an antigen-binding fragment thereof, and (b) at least one of lapatinib, regorafenib, vemurafenib or a combination thereof, to a subject in need thereof, and a pharmaceutical composition comprising (a) an anti-c-Met antibody or an antigen-binding fragment thereof, and (b) at least one of lapatinib, regorafenib, vemurafenib, or a combination thereof are provided.
    Type: Grant
    Filed: November 15, 2013
    Date of Patent: August 1, 2017
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Seung Hyun Lee, Geun Woong Kim, Kyung Ah Kim, Hye Won Park, Ho Yeong Song, Young Mi Oh, Saet Byoul Lee, Ji Min Lee, Kwang Ho Cheong, Yun Ju Jeong, Mi Young Cho, Jae Hyun Choi, Yun Jeong Song, Yoon Aa Choi
  • Anti-c-Met/anti-EGFR bispecific antibodies
    Patent number: 9657104
    Abstract: There are provided an anti-c-Met/anti-EGFR bispecific antibody, a method for treating cancer using the same, and an anti-EGFR scFv fragment.
    Type: Grant
    Filed: March 31, 2014
    Date of Patent: May 23, 2017
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Mi Young Cho, Seung Hyun Lee, Kwang Ho Cheong, Powei Lin, Jae Woong Hwang, Christina Yi, Young Jun Koh
  • Anti-Her3 scFV fragment and bispecific anti-c-Met/anti-Her3 antibodies comprising the same
    Patent number: 9505843
    Abstract: Provided is an anti-Her3 antibody or antigen-binding fragment thereof, an anti-c-Met/anti-Her3 bispecific antibody including the same, and a method of preventing and/or treating a cancer using the same.
    Type: Grant
    Filed: November 21, 2014
    Date of Patent: November 29, 2016
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Min-Kyung Kim, Kwang Ho Cheong, Mi Young Cho, Powei Lin
  • Anti-EGFR/anti-HER2 bispecific antibodies with anti-EGFR DARPins
    Patent number: 9499622
    Abstract: An anti-EGFR/anti-HER2 bispecific antibody including an anti-EGFR DARPin and an anti-HER2 antibody, a pharmaceutical composition including the bispecific antibody, a method of preparing the bispecific antibody, and a method of reducing a side effect and/or enhancing efficacy of an anti-HER2 antibody using an anti-EGFR DARPin.
    Type: Grant
    Filed: February 18, 2015
    Date of Patent: November 22, 2016
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Kwang Ho Cheong, Seung Hyun Lee, Powei Lin, Saet Byoul Lee, Jae Woong Hwang
  • Antibody specifically binding to epitope in SEMA domain of c-Met
    Patent number: 9394367
    Abstract: An antibody or antigen binding fragment thereof that specifically binds to an epitope in a SEMA domain of c-Met protein, and pharmaceutical compositions, methods, kits, nucleic acids, and cells related thereto.
    Type: Grant
    Filed: October 5, 2012
    Date of Patent: July 19, 2016
    Assignee: SAMSUNG ELECTRONICS CO., LTD
    Inventors: Kwang-ho Cheong, Kyung-ah Kim, Seung-hyun Lee, Ho-yeong Song, Yun-jeong Song, Young-mi Oh, Soo-yeon Jung, Mi-young Cho
  • Method of target membrane protein depletion
    Patent number: 9388243
    Abstract: A method of target membrane protein depletion comprising treating a cell with a dual binding molecule comprising a first binding domain which binds to a driver membrane protein and a second binding domain which binds to a target membrane protein, wherein the cell comprises a cell membrane, and the driver membrane protein and target membrane protein are associated with the cell membrane where the target membrane protein positions, and are internalized into a cell and degraded when the first binding domain of the dual binding molecule binds the driver membrane protein; as well as related methods and compositions.
    Type: Grant
    Filed: May 29, 2014
    Date of Patent: July 12, 2016
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Kwang Ho Cheong, Seung Hyun Lee, Mi Young Cho, Young Jun Koh, Lin Powei, Christina Yi, Jae Woong Hwang
  • Bispecific chimeric proteins comprising DARPins
    Patent number: 9359440
    Abstract: A bispecific chimeric protein including a designed ankyrin repeat protein (DARPin), and an IgG antibody, an scFv-Fc antibody fragment, or a combination thereof, linked to the DARPin; a method for treating or preventing cancer using the same; and related methods and compositions.
    Type: Grant
    Filed: July 28, 2014
    Date of Patent: June 7, 2016
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Kwang Ho Cheong, Young Jun Koh, Min-Kyung Kim, Powei Lin, Seung Hyun Lee, Jung Wook Lee, Mi Young Cho, Jae Woong Hwang
  • Humanized and affinity-matured anti-c-Met antibody and uses thereof
    Patent number: 9249221
    Abstract: Provided is a humanized and affinity-matured anti-c-Met antibody, a pharmaceutical composition including the antibody, and a method of preventing and/or treating c-Met-related disease using the antibody.
    Type: Grant
    Filed: March 31, 2014
    Date of Patent: February 2, 2016
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Seung Hyun Lee, Kyung Ah Kim, Kwang Ho Cheong, Ho Yeong Song
  • ANTI-HER2 ANTIBODY AND ANTI-C-MET/ANTI-HER2 BISPECIFIC ANTIBODIES COMPRISING THE SAME
    Publication number: 20150322162
    Abstract: An anti-HER2 antibody, an anti-c-Met/anti-HER2 bispecific antibody including the same, method for preparing same, and a method of preventing and/or treating a cancer using the same are provided.
    Type: Application
    Filed: May 11, 2015
    Publication date: November 12, 2015
    Inventors: Mi Young CHO, Powei LIN, Kwang Ho CHEONG, Jae Woong HWANG, Geun Woong KIM, Han Na CHOI
  • ANTI-CMET/ANTI-EGFR/ANTI-HER3 MULTIPECIFIC ANTIBODIES AND USE THEREOF
    Publication number: 20150322165
    Abstract: An anti-EGFR/anti-HER3 antibody or antigen binding fragment thereof, and a method of preventing and/or treating a cancer using the same
    Type: Application
    Filed: April 22, 2015
    Publication date: November 12, 2015
    Inventors: Kwang Ho Cheong, Jae Woong Hwang, Seung Hyun Lee, Powei Lin, Mi Young Cho
  • ANTI-EGFR/ANTI-HER2 BISPECIFIC ANTIBODIES WITH ANTI-EGFR DARPINS
    Publication number: 20150232573
    Abstract: An anti-EGFR/anti-HER2 bispecific antibody including an anti-EGFR DARPin and an anti-HER2 antibody, a pharmaceutical composition including the bispecific antibody, a method of preparing the bispecific antibody, and a method of reducing a side effect and/or enhancing efficacy of an anti-HER2 antibody using an anti-EGFR DARPin.
    Type: Application
    Filed: February 18, 2015
    Publication date: August 20, 2015
    Inventors: Kwang Ho Cheong, Seung Hyun Lee, Powei Lin, Saet Byoul Lee, Jae Woong Hwang
  • Anti c-Met humanized antibody and uses thereof
    Patent number: 9101610
    Abstract: An anti c-Met antibody, a composition comprising the antibody, and a method for preventing or treating cancer by administering the composition is provided.
    Type: Grant
    Filed: August 20, 2012
    Date of Patent: August 11, 2015
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Kwang Ho Cheong, Seunghyun Lee, Geun Woong Kim, Kyung-Ah Kim, Young Mi Oh, Saet Byoul Lee, Soo-yeon Jung, Yunju Jeong, Young Kue Han
  • COMBINATION THERAPY USING BISPECIFIC ANTI-C-MET/ANTI-EGFR ANTIBODY AND C-SRC INHIBITOR
    Publication number: 20150216972
    Abstract: Pharmaceutical composition including a bispecific anti-c-Met/anti-EGFR antibody and a c-Src inhibitor and a method of preventing and/or treating cancer including co-administering a bispecific anti-c-Met/anti-EGFR antibody and a c-Src inhibitor to a subject in need thereof.
    Type: Application
    Filed: January 20, 2015
    Publication date: August 6, 2015
    Inventors: Powei Lin, Kwang Ho Cheong, Young Jun Koh, Jae-woong Hwang, Seung Hyun Lee, Jung Wook Lee
  • ANTI-HER3 SCFV FRAGMENT AND BISPECIFIC ANTI-C-MET/ANTI-HER3 ANTIBODIES COMPRISING THE SAME
    Publication number: 20150210766
    Abstract: Provided is an anti-Her3 antibody or antigen-binding fragment thereof, an anti-c-Met/anti-Her3 bispecific antibody including the same, and a method of preventing and/or treating a cancer using the same.
    Type: Application
    Filed: November 21, 2014
    Publication date: July 30, 2015
    Inventors: Min-Kyung KIM, Kwang Ho CHEONG, Mi Young CHO, Powei LIN